Weill Medical College Of Cornell University
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1865-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://weill.cornell.edu
Assessing Anterior Cingulate Brain Activity in People With Late-Life Depression
- First Posted Date
- 2009-06-23
- Last Posted Date
- 2015-08-11
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 76
- Registration Number
- NCT00926653
- Locations
- 🇺🇸
New York Presbyterian-Weill Cornell Medical College, White Plains, New York, United States
Aging Brain Changes, Executive Dysfunction and Depression
- First Posted Date
- 2009-06-11
- Last Posted Date
- 2017-05-12
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 116
- Registration Number
- NCT00918684
A Study to Evaluate the Safety and Efficacy of Dasatinib (Sprycel) in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
- First Posted Date
- 2009-06-11
- Last Posted Date
- 2018-08-31
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 2
- Registration Number
- NCT00918463
- Locations
- 🇺🇸
Weill Cornell Medical College, New York, New York, United States
Conditioning Regimen of Bendamustine and Melphalan Followed by Transplant in Patients With Multiple Myeloma
- First Posted Date
- 2009-06-09
- Last Posted Date
- 2019-06-04
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 57
- Registration Number
- NCT00916058
- Locations
- 🇺🇸
Weill Cornell Medical College, New York, New York, United States
Docetaxel/Prednisone Plus Fractionated 177Lu- J591 Antibody for Metastatic, Castrate-resistant Prostate Cancer
Phase 1
Completed
- Conditions
- Prostate Cancer
- Interventions
- First Posted Date
- 2009-06-09
- Last Posted Date
- 2021-05-20
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 15
- Registration Number
- NCT00916123
- Locations
- 🇺🇸
Weill Cornell Medical College, New York, New York, United States
🇺🇸University of North Carolina Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States
Thrombocytopenia and Bleeding in Wiskott-Aldrich Syndrome (WAS) Patients
Phase 2
Terminated
- Conditions
- Wiskott-Aldrich SyndromeBleedingThrombocytopenia
- Interventions
- Diagnostic Test: blood drawing in patients with WASDiagnostic Test: blood drawing in healthy controls
- First Posted Date
- 2009-05-28
- Last Posted Date
- 2019-03-18
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 24
- Registration Number
- NCT00909363
- Locations
- 🇺🇸
Weill Cornell Medical College, New York, New York, United States
Photodynamic Therapy (PDT) Trial for Palliation of Cholangiocarcinoma
Phase 3
Terminated
- Conditions
- Cholangiocarcinoma
- Interventions
- Procedure: ERCP and Photodynamic TherapyProcedure: ERCP only
- First Posted Date
- 2009-05-22
- Last Posted Date
- 2015-06-03
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 50
- Registration Number
- NCT00907413
- Locations
- 🇺🇸
University of Virginia, Charlotteville, Virginia, United States
Eltrombopag and the Bcl-extra-large (xL) Pathway in Idiopathic Thrombocytopenic Purpura (ITP)
Phase 2
Completed
- Conditions
- Immune Thrombocytopenia
- Interventions
- First Posted Date
- 2009-05-14
- Last Posted Date
- 2019-03-18
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 20
- Registration Number
- NCT00902018
- Locations
- 🇺🇸
Weill Cornell Medical College, New York, New York, United States
Intra-arterial Chemotherapy(Chemosurgery) for Retinoblastoma
Phase 1
Completed
- Conditions
- Retinoblastoma
- First Posted Date
- 2009-05-13
- Last Posted Date
- 2009-12-17
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 100
- Registration Number
- NCT00901238
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸Weill Medical College of Cornell University, New York, New York, United States
Pilot Study of Abbreviated Chemotherapy Based on Positron Emission Tomography (PET) Scan in Hodgkin's Lymphoma
Not Applicable
Terminated
- Conditions
- Hodgkin's Lymphoma
- Interventions
- Drug: ABVD chemotherapy
- First Posted Date
- 2009-05-13
- Last Posted Date
- 2018-08-31
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 6
- Registration Number
- NCT00901303
- Locations
- 🇺🇸
Weill Cornell Medical College, New York, New York, United States
© Copyright 2025. All Rights Reserved by MedPath